Hologic übernimmt den Marktführer für Biopsiemarker und Lokalisierungstechnologien SOMATEX für 64 Millionen US-Dollar pressnetwork.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pressnetwork.de Daily Mail and Mail on Sunday newspapers.
Hologic To Acquire SOMATEX, Leader In Biopsy Site Markers And Localization Technologies, For $64M
Deal further expands Hologic’s portfolio of world-class breast health solutions addressing the full continuum of care
Hologic, Inc., an innovative medical technology company primarily focused on improving women’s health, announced today it has completed the acquisition of SOMATEX Medical Technologies GmbH, a leader in biopsy site markers and localization technologies, for approximately $64M. The company was previously owned by E-Med Solutions GmbH, Berlin, a group of investors led by German private equity company Westlake Partners.
The transaction supports Hologic’s strategy to provide a comprehensive suite of innovative solutions across the continuum of breast health care. Specifically, SOMATEX’s differentiated products will enable Hologic to strengthen and further expand its breast marker portfolio, which has been growing consistently. As a result of the acquisition, Hologi